Fujirebio Europe is an R&D-driven company that has been at the forefront of developing innovative technologies and biomarkers with high clinical value for over 50 years. With a mission to create new value in healthcare, Fujirebio is dedicated to contributing to human health and the future of medical care. They are recognized as a proven pioneer and partner in the diagnostics industry, constantly developing new solutions for a wide range of clinical areas.

Fujirebio offers a comprehensive range of products and services, including instruments such as LUMIPULSE® G, TENDIGO™, RoboBlot™, Auto-LIA™, and Auto-LiPA™, which enable fully automated or manual/semi-automated testing. They also provide a variety of testing kits for different diseases and disorders, including autoimmune diseases, bone metabolism, cardiac conditions, diabetes, fertility, genetic disorders, hypertension, infectious diseases, inflammation, neurodegeneration, transplantation, tumor markers, and more. With their expertise and experience, Fujirebio has established themselves as a trusted partner in the diagnostics market, continually pushing boundaries and providing high-quality solutions that improve patient care